| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |